Oceaneering International Inc
$4.93B- Market cap
- $5.14B
- Debt
- +$487.42M
- Cash
- −$695.87M
Capital structure 91% equity / 9% debt · EV / Revenue 1.77x · EV / EBITDA 11.60x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: OII stock price at discount vs OCGN $51.60 current versus $2.92K implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at OCGN's multiple
Implied fair value · at OII's multiple
Snapshot Sep 8, 10:37 AM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: OII FY 2025 (ended Dec 31, 2025) · OCGN FY 2025 (ended Dec 31, 2025).
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 91% equity / 9% debt · EV / Revenue 1.77x · EV / EBITDA 11.60x
Capital structure 94% equity / 6% debt · EV / Revenue 106.82x
OII carries the larger enterprise value at $4.93B against $471.41M; OII trades on the lower EV / Revenue multiple (1.77x vs 106.82x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
OCEANEERING INTERNATIONAL INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
OCUGEN, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.46x
-2.37x
Net debt / EBITDA
Leverage against operating earnings
-0.49x
-0.16x
Cash and equivalents
Liquid reserves on the balance sheet
$695.87M
$18.57M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
HELIX ENERGY SOLUTIONS GROUP INC
OII vs HLX
Baker Hughes Co
OII vs BKR
NOV Inc.
OII vs NOV
Helmerich & Payne, Inc.
OII vs HP
NABORS INDUSTRIES LTD
OII vs NBR
Transocean Ltd.
OII vs RIG
IOVANCE BIOTHERAPEUTICS, INC.
OII vs IOVA
bluebird bio, Inc.
OII vs BLUE
BioNTech SE
OII vs BNTX
Moderna, Inc.
OII vs MRNA
Legend Biotech Corp
OII vs LEGN
Arcturus Therapeutics Holdings Inc.
OII vs ARCT
$487.42M
$28.79M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.